Candesartan cilexetil
SIGMA/SML0245 - ≥98% (HPLC)
Synonym: 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid 1-
CAS Number: 145040-37-5
Empirical Formula (Hill Notation): C33H34N6O6
Molecular Weight: 610.66
MDL Number: MFCD00871371
Linear Formula: C33H34N6O6
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C33H34N6O6/c1-3-42-32- |
InChI key | GHOSNRCGJFBJIB-UHFFFAOYSA |
originator | Takeda |
Quality Level | 100 ![]() |
SMILES string | CCOc1nc2cccc(C(=O)OC(C)OC |
solubility | DMSO: ≥15 mg/mL |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Candesartan cilexetil is the prodrug form of the potent angiotensin II receptor antagonist, candesartan. The prodrug is cleaved by esterases within the intestine to liberate the active molecule. |
Features and Benefits: | This compound is featured on the Angiotensin Receptors ![]() ![]() |
Features and Benefits: | This compound was developed by Takeda ![]() ![]() |
Packaging: | 10 mg in glass bottle |
Packaging: | 50 mg in poly bottle |
Symbol | ![]() ![]() |
Signal word | Warning |
Hazard statements | H361 - H400 |
Precautionary statements | P201 - P273 - P308 + P313 |
Hazard Codes | T,N |
Risk Statements | 61-48/20-50 |
Safety Statements | 53-45-61 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |